PHARMACY

Upsher-Smith Laboratories will launch vigabatrin for oral solution under the brand name Vigadrone under the agreement.

QS/1 is partnering with Surescripts to adopt the Centers for Medicare and Medicaid Services’ new standard for e-prescriptions.

CVS Health has kicked off its annual Project Health campaign, which has provided more than $122 million worth of free health services since 2006.

LexisNexis Risk Solutions’ Bobbie Riley and Erin Benson, take a look at the need to more closely control the dispensing of prescriptions and controlled substances to help curb the opioid epidemic.

Medly, a year-old pharmacy in Brooklyn’s Williamsburg neighborhood, is entering the fray by delivering prescription drugs to patients throughout New York City’s five boroughs.

Lupin has received the FDA’s green light for a generic version of Genus’ potassium chloride oral solution in two dosage strengths.

Ed Vess discusses how state efforts make it easier to bill some payers as federal provider status lags.

Amneal and American Regent have reached a five-year deal for generic Makena, an injectable intended to reduce preterm births in women.